EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: Differential and interactive effects on novelty-induced hyperlocomotion, blood cytokine levels and TLR4-related processes

Yuri Aono, Koji Saito, Hiroki Kawashima, Arata Watanabe, Tetsuro Kono iD, Tomomi Hashizume-Takizawa, Hiroyuki Okada, Yasuhiro Kosuge, Hidenobu Senpuku, John L Waddington, Tadashi Saigusa iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0292830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Yuri Aono und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Sakaecho-Nishi, Matsudo, Chiba, Japan. Hauptthemen laut MEDLINE: Porphyromonas gingivalis, Toll-Like Receptor 4, Lipopolysaccharides, Escherichia coli. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Nihon University, Nakatomi Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipopolysaccharide (LPS), a component of the Gram-negative bacterial cell wall, activates Toll-like receptors (TLRs). Porphyromonas gingivalis ( Pg ) may be involved in the progression of periodontal disease. Mice exposed to a novel environment show hyperlocomotion that is inhibited by systemic administration of LPS derived from Escherichia coli ( Ec -LPS). However, whether Pg -LPS influences novelty-induced locomotion is unknown. Accordingly, we carried out an open field test to analyse the effects of Pg -LPS. For comparison, effects of Ec -LPS were also studied. We additionally investigated the influence of systemic administration of Pg -LPS or Ec -LPS on IL-6, TNF-alpha, and IL-10 levels in blood, as they could be involved in the changes in locomotion. The TLR4 receptor antagonist TAK-242 was used to study the involvement of TLR4. Since Pg -LPS may block TLR4 in vitro , we analysed the effects of Pg -LPS on Ec -LPS-induced changes in behavioural and biochemical parameters. Male ddY mice were used. Pg - or Ec -LPS and TAK-242 were administered intraperitoneally. Ec -LPS (840 μg/kg), but not Pg -LPS (100, 500 and 840 μg/kg), inhibited novelty-induced locomotion, which was antagonized by TAK-242 (3.0 mg/kg). Ec -LPS (840 μg/kg) increased blood levels of IL-6 and IL-10, which were antagonized by TAK-242 (3.0 mg/kg). However, TAK-242 did not inhibit Ec -LPS-induced increases in TNF-alpha levels in blood. Pg -LPS (100, 500, and 840 μg/kg) did not alter blood IL-6, TNF-alpha, or IL-10 levels. The Ec -LPS-induced increase in blood IL-10, but not IL-6 and TNF-alpha, levels was inhibited by Pg -LPS (500 μg/kg). These results suggest that TLR4 stimulation mediates the inhibition of novel environment-induced locomotion in mice following systemic administration of Ec -LPS, while also increasing blood IL-6 and IL-10 levels. In contrast, Pg -LPS did not exhibit these effects. The present study also provides in vivo evidence that Pg -LPS can inhibit TLR4-mediated increases in blood levels of IL-10, a cytokine thought to prevent the development of periodontal disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porphyromonas gingivalisToll-Like Receptor 4LipopolysaccharidesEscherichia coliAnimalsMiceMaleLocomotionCytokinesInterleukin-6Interleukin-10Tumor Necrosis Factor-alphaSulfonamides

Substanzen

Toll-Like Receptor 4LipopolysaccharidesCytokinesInterleukin-6Interleukin-10Tlr4 protein, mouseTumor Necrosis Factor-alphaethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylateSulfonamides

Autor:innen und Institutionen

  • Department of Pharmacology, Nihon University School of Dentistry at Matsudo, Sakaecho-Nishi, Matsudo, Chiba, Japan.
  • Nihon University Graduate School of Dentistry at Matsudo, Oral Molecular Pharmacology, Sakaecho-Nishi, Matsudo, Chiba, Japan.
  • Department of Histology, Nihon University School of Dentistry at Matsudo, Sakaecho-Nishi, Matsudo, Chiba, Japan.
  • Department of Microbiology and Immunology, Nihon University School of Dentistry at Matsudo, Sakaecho-Nishi, Matsudo, Chiba, Japan.
  • Laboratory of Pharmacology, Nihon University School of Pharmacy, Narashinodai, Funabashi, Chiba, Japan.
  • School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, St. Stephen's Green, Dublin, Ireland.

ORCID-Profile: Tetsuro Kono, Tadashi Saigusa

Förderung

  • Japan Society for the Promotion of Science
  • Nihon University
  • Nakatomi Foundation
  • Suzuki Fund, Nihon University School of Dentistry at Matsudo
  • Research Institute of Oral Science, Nihon University School of Dentistry at Matsudo

Zitieren

APA

Aono, Y., Saito, K., Kawashima, H., Watanabe, A., Kono, T., Hashizume-Takizawa, T., Okada, H., Kosuge, Y., Senpuku, H., Waddington, J. L., & Saigusa, T. (2024). Lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: Differential and interactive effects on novelty-induced hyperlocomotion, blood cytokine levels and TLR4-related processes. PLOS ONE. https://doi.org/10.1371/journal.pone.0292830

Vancouver

Aono Y, Saito K, Kawashima H, Watanabe A, Kono T, Hashizume-Takizawa T, et al. Lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: Differential and interactive effects on novelty-induced hyperlocomotion, blood cytokine levels and TLR4-related processes. PLOS ONE. 2024. doi:10.1371/journal.pone.0292830

BibTeX
@article{Aono2024,
  author = {Aono, Yuri and Saito, Koji and Kawashima, Hiroki and Watanabe, Arata and Kono, Tetsuro and Hashizume-Takizawa, Tomomi and Okada, Hiroyuki and Kosuge, Yasuhiro and Senpuku, Hidenobu and Waddington, John L and Saigusa, Tadashi},
  title = {Lipopolysaccharides derived from Porphyromonas gingivalis and Escherichia coli: Differential and interactive effects on novelty-induced hyperlocomotion, blood cytokine levels and TLR4-related processes},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0292830}
}
Kostenlos starten →